Enlivex Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Enlivex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enlivex Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enlivex Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $9.6k | 9.2k | 1.04 |
| 2025-06-30 | $10k | 9.2k | 1.12 |
| 2025-03-31 | $8.9k | 9.2k | 0.97 |
| 2024-12-31 | $11k | 9.2k | 1.17 |
| 2024-09-30 | $15k | 9.2k | 1.68 |
| 2024-06-30 | $13k | 9.2k | 1.42 |
| 2024-03-31 | $38k | 10k | 3.79 |
| 2023-12-31 | $27k | 10k | 2.70 |
| 2023-09-30 | $14k | 8.9k | 1.58 |
| 2023-06-30 | $23k | 8.9k | 2.63 |
| 2022-12-31 | $46k | 12k | 3.94 |
| 2022-09-30 | $77k | 18k | 4.27 |
| 2022-06-30 | $56k | 12k | 4.53 |
| 2022-03-31 | $87k | 16k | 5.57 |
| 2021-12-31 | $76k | 12k | 6.23 |
| 2021-09-30 | $132k | 13k | 10.00 |
| 2021-06-30 | $195k | 20k | 10.00 |
| 2021-03-31 | $199k | 18k | 11.07 |
| 2020-12-31 | $2.0k | 200 | 10.00 |